BSRC Alexander Fleming

BSRC "Alexander Fleming" Publications - 2017

2017 - (20)

Nikolaou KC, Moulos P, Harokopos V, Chalepakis G, Talianidis I. 2017, "Kmt5a Controls Hepatic Metabolic Pathways by Facilitating RNA Pol II Release from Promoter-Proximal Regions.", Cell Rep., 2017 Jul 25; 20(4):909-922. doi: 10.1016/j.celrep.2017.07.003 [PubMed].

Liakos A, Lavigne MD, Fousteri M. 2017, "Nucleotide Excision Repair: From Neurodegeneration to Cancer.", Adv Exp Med Biol. , 2017;1007:17-39. doi: 10.1007/978-3-319-60733-7_2. [PubMed].

Paoli M, Münch D, Haase A, Skoulakis EMC, Turin L, Galizia CG. 2017, "Minute Impurities Contribute Significantly to Olfactory Receptor Ligand Studies: Tales from Testing the Vibration Theory", eNeuro. , 2017 Jun 19; 4(3). pii: ENEURO.0070-17.2017. doi: 10.1523/ENEURO.0070-17.2017. eCollection 2017 May-Jun. [PubMed].

Kaklamanos A, Rozman J, Roulis M, Karagianni N, Armaka M, Wu M, Brachthäuser L, Calzada-Wack J, Horsch M, Beckers J, Rathkolb B, Adler T, Neff F, Wolf E, Gailus-Durner V, Fuchs H, de Angelis MH, Kollias G. 2017, "Extensive phenotypic characterization of a new transgenic mouse reveals pleiotropic perturbations in physiology due to mesenchymal hGH minigene expression.", Sci Rep. , 2017 May 25; 7(1):2397. doi: 10.1038/s41598-017-02581-8. [PubMed].

Sealey MA, Vourkou E, Cowan CM, Bossing T, Quraishe S, Grammenoudi S, Skoulakis EMC, Mudher A. 2017, "Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy.", Neurobiol Dis. , 2017 May 11; 105:74-83. doi: 10.1016/j.nbd.2017.05.003. [Epub ahead of print] [PubMed].

Tzouvelekis A, Bouros D, Aidinis V. 2017, "Biomarkers in Idiopathic Pulmonary Fibrosis: A RAGE-ing Bull in the Arena", Ann Am Thorac Soc., 2017 May; 14(5):613-614 [PubMed].

Melagraki G, Ntougkos E, Rinotas V, Papaneophytou C, Leonis G, Mavromoustakos T, Kontopidis G, Douni E, Afantitis A, Kollias G. 2017, "Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)", PLoS Comput Biol., 2017 Apr 20; 13(4):e1005372. doi: 10.1371/journal.pcbi.1005372 [PubMed].

Ntougkos E, Chouvardas P, Roumelioti F, Ospelt C, Frank-Bertoncelj M, Filer A, Buckley CD, Gay S, Nikolaou C, Kollias G. 2017, "Genomic responses of mouse synovial fibroblasts during TNF-driven arthritogenesis greatly mimic those of human rheumatoid arthritis", Arthritis Rheumatol, 2017 Apr 13. doi: 10.1002/art.40128 [PubMed].

Terzenidou ME, Segklia A, Kano T, Papastefanaki F, Karakostas A, Charalambous M, Ioakeimidis F, Papadaki M, Kloukina I, Chrysanthou-Piterou M, Samiotaki M, Panayotou G, Matsas R, Douni E. 2017, "Novel insights into SLC25A46-related pathologies in a genetic mouse model", PLoS Genet, Apr 4;13(4): e1006656. doi: 10.1371 [PubMed].

Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A. 2017, "Lung cancer in patients with idiopathic pulmonary fibrosis", Pulm Pharmacol Ther., 2017 Apr 1 [PubMed].

Koliaraki V, Pallangyo CK, Greten FR, Kollias G. 2017, "Mesenchymal Cells in Colon Cancer", Gastroenterology, 2017 Apr;152(5): 964-979. doi: 10.1053/j.gastro.2016.11.049. Review [PubMed].

Frank-Bertoncelj M, Trenkmann M, Klein K, Karouzakis E, Rehrauer H, Bratus A, Kolling C, Armaka M, Filer A, Michel BA, Gay RE, Buckley CD, Kollias G, Gay S, Ospelt C. 2017, "Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions", Nat Commun., 2017 Mar 23; 8:14852. doi: 10.1038/ncomms14852 [PubMed].

Tomos IP, Tzouvelekis A, Aidinis V, Manali ED, Bouros E, Bouros D, Papiris SA. 2017, "Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers’", Expert Rev Respir Med, 2017 Mar 8 :1-11. [PubMed].

Tzouvelekis A, Yu G, Lacks Lino Cardenas C, Herazo-Maya JD, Wang R, Woolard T, Zhang Y, Sakamoto K, Lee H, Yi JS, DeIuliis G, Xylourgidis N, Ahangari F, Lee PJ, Aidinis V, Herzog EL, Homer R, Bennett AM, Kaminski N. 2017, "SH2 Domain-containing Phosphatase-SHP-2 is a Novel Anti-fibrotic Regulator in Pulmonary Fibrosis", Am J Respir Crit Care Med., 2017 Feb 15; 195(4):500-514. [PubMed].

Anas AA, Claushuis TA, Mohan RA, Christoffels VM, Aidinis V, Florquin S, Van't Veer C, Hou B, de Vos AF, van der Poll T. 2017, "Epithelial Myeloid-differentiation Factor 88 is Dispensable During Klebsiella Pneumonia", Am J Respir Cell Mol Biol., 2017 Feb 10. [PubMed].

Tzouvelekis A, Tzilas V, Papiris S, Aidinis V, Bouros D. 2017, "Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis A patient "Q and A" approach", Pulm Pharmacol Ther., 2017 Feb; 42:21-24. [PubMed].

Mansilla A, Chaves-Sanjuán A, Campillo N E, Semelidou O, Martínez-González L, Infantes L, González-Rubio J M, Gil C, Conde S, Skoulakis EMC, Ferrús A, Martínez A, Sánchez-Barrena M J. 2017, "Phenothiazines regulate synaptic function by interfering the NCS-1/Ric8a complex: a novel approach for Fragile X Syndrome", Proc Natl Acad Sci U S A, 114(6) :E999-E1008. doi: 10.1073/pnas.1611089114 [PubMed].

Fouka P., Alexopoulos H., Chatzi I., Dedos S. G., Samiotaki M., Panayotou G., Politis P., Tzioufas A., Dalakas M. C. 2017, "Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease.", Neurology: Neuroimmunology & Neuroinflammation, 2016 Dec 5; 4(1):e306. eCollection 2017 Jan [PubMed].

Mylonis I., Kourti M., Samiotaki M., Panayotou G., Simos G. 2017, "Mortalin-mediated and ERK-controlled targeting of HIF-1α to mitochondria confers resistance to apoptosis under hypoxia", J Cell Sci. , 2017 Jan 15; 130(2):466-479. doi: 10.1242/jcs.195339. Epub 2016 Dec 1. [PubMed].

Le Guével R, Oger F, Martinez-Jimenez CP, Bizot M, Gheeraert C, Firmin F, Ploton M, Kretova M, Palierne G, Staels B, Barath P, Talianidis I, Lefebvre P, Eeckhoute J, Salbert G. 2017, "Inactivation of the Nuclear Orphan Receptor COUP-TFII by Small Chemicals.", ACS Chem Biol., 2017 Mar 17; 12(3):654-663. doi: 10.1021/acschembio.6b00593. Epub 2017 Jan 13. [PubMed].